tykhr
sign in
free sign up
Corvus Pharmaceuticals Inc
Biotechnology
Healthcare
CRVS
77.77 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
6.04
52 week high
9.56
high
6.27
52 week low
0.00
low
6.00
growth
3.55 %
previous Close
6.04
P/E ratio
market cap
452 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-8.00 M
-152.64 %
eps
0.00 %
27.43 %
eps surprise
23.08 %
net profit margin
-799800000.00 %
0.00 %
operating incoming
-10.26 M
-3.41 %
net change in cash
9.69 M
359.08 %
cash on hand
14.69 M
193.88 %
cost of revenue
29.00 K
0.00 %
top